| Year |
Citation |
Score |
| 2023 |
Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, ... ... Sun CC, et al. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. PMID 38009662 DOI: 10.1002/cncr.35126 |
0.307 |
|
| 2022 |
Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LA. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 32: 1153-1163. PMID 36166208 DOI: 10.1136/ijgc-2022-003696 |
0.3 |
|
| 2022 |
Gershenson DM, Cobb LP, Westin SN, Zhang Y, Jazaeri A, Malpica A, Sun CC. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecologic Oncology. PMID 36137845 DOI: 10.1016/j.ygyno.2022.09.005 |
0.311 |
|
| 2022 |
Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm K, Giordano SH, Meyer LA. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. American Journal of Obstetrics and Gynecology. PMID 35500609 DOI: 10.1016/j.ajog.2022.04.045 |
0.316 |
|
| 2021 |
Harrison RF, Cantor SB, Sun CC, Villanueva M, Westin SN, Fleming ND, Toumazis I, Sood AK, Lu KH, Meyer LA. Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecologic Oncology. PMID 33536126 DOI: 10.1016/j.ygyno.2021.01.024 |
0.327 |
|
| 2020 |
Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, et al. Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer. American Journal of Obstetrics and Gynecology. PMID 32805208 DOI: 10.1016/J.Ajog.2020.08.032 |
0.4 |
|
| 2020 |
Cobb LP, Sun CC, Iyer R, Nick AM, Fleming ND, Westin SN, Sood AK, Wong KK, Silva EG, Gershenson DM. The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecologic Oncology. PMID 32709538 DOI: 10.1016/J.Ygyno.2020.06.498 |
0.351 |
|
| 2020 |
Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 32616627 DOI: 10.1136/Ijgc-2020-001243 |
0.425 |
|
| 2020 |
Slomovitz B, Gourley C, Carey MS, Malpica A, Shih IM, Huntsman D, Fader AN, Grisham RN, Schlumbrecht M, Sun CC, Ludemann J, Cooney GA, Coleman R, Sood AK, Mahdi H, et al. Low-grade serous ovarian cancer: State of the science. Gynecologic Oncology. PMID 31969252 DOI: 10.1016/J.Ygyno.2019.12.033 |
0.367 |
|
| 2020 |
Meyer L, Schneider A, Chen TH, Wang XS, Sun CC. Financial toxicity and patient-reported outcomes over time: A longitudinal study of women with recurrent ovarian cancer. Journal of Clinical Oncology. 38: 6079-6079. DOI: 10.1200/Jco.2020.38.15_Suppl.6079 |
0.447 |
|
| 2019 |
Bednar EM, Sun CC, McCurdy S, Vernon SW. Assessing relatives' readiness for hereditary cancer cascade genetic testing. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31857708 DOI: 10.1038/S41436-019-0735-3 |
0.341 |
|
| 2019 |
Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 31843871 DOI: 10.1136/Ijgc-2019-000999 |
0.359 |
|
| 2019 |
Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LA. Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecologic Oncology. PMID 31208738 DOI: 10.1016/J.Ygyno.2019.06.003 |
0.304 |
|
| 2019 |
Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Atypical Hyperplasia. American Journal of Obstetrics and Gynecology. PMID 31128110 DOI: 10.1016/J.Ajog.2019.05.029 |
0.388 |
|
| 2019 |
Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. American Journal of Obstetrics and Gynecology. PMID 30965052 DOI: 10.1016/J.Ajog.2019.04.005 |
0.379 |
|
| 2019 |
Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecologic Oncology. 152: 514-521. PMID 30876497 DOI: 10.1016/J.Ygyno.2018.11.027 |
0.367 |
|
| 2019 |
Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PT. Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecologic Oncology. 152: 501-508. PMID 30876495 DOI: 10.1016/J.Ygyno.2018.10.044 |
0.367 |
|
| 2019 |
Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecologic Oncology. 152: 439-444. PMID 30876486 DOI: 10.1016/J.Ygyno.2018.11.005 |
0.388 |
|
| 2019 |
Bednar EM, Sun CC, Camacho B, Terrell J, Rieber AG, Ramondetta LM, Freedman RS, Lu KH. Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic. Gynecologic Oncology. 152: 328-333. PMID 30528888 DOI: 10.1016/J.Ygyno.2018.12.001 |
0.304 |
|
| 2019 |
Harrison R, Cantor SB, Villanueva M, Suidan RS, Sun CC, Rauh-Hain JA, Westin SN, Fleming ND, Sood AK, Lu KH, Meyer L. Cost-effectiveness analysis of laparoscopic disease assessment in ovarian cancer. Journal of Clinical Oncology. 37: 5556-5556. DOI: 10.1200/Jco.2019.37.15_Suppl.5556 |
0.412 |
|
| 2019 |
Suidan R, Sun C, Lu K, Giordano S, Meyer L. A prospective assessment of patient preferences in ovarian cancer: What do patients value the most? Gynecologic Oncology. 153: e12. DOI: 10.1016/J.YGYNO.2019.03.133 |
0.317 |
|
| 2018 |
Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA. Disparities in treatment and survival among elderly ovarian cancer patients. Gynecologic Oncology. PMID 30253875 DOI: 10.1016/J.Ygyno.2018.08.041 |
0.431 |
|
| 2018 |
Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH. Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecologic Oncology. PMID 29961559 DOI: 10.1016/J.Ygyno.2018.06.020 |
0.451 |
|
| 2018 |
Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecologic Oncology. PMID 29735278 DOI: 10.1016/J.Ygyno.2018.04.564 |
0.377 |
|
| 2018 |
Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecologic Oncology. PMID 29622276 DOI: 10.1016/J.Ygyno.2018.03.054 |
0.444 |
|
| 2018 |
Schlumbrecht M, Sun C, Huang M, Milbourne A, Bodurka D. Gynecologic cancer survivor preferences for long-term surveillance. Bmc Cancer. 18: 375. PMID 29614979 DOI: 10.1186/S12885-018-4313-X |
0.413 |
|
| 2018 |
Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH. Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 29303933 DOI: 10.1097/Igc.0000000000001165 |
0.396 |
|
| 2018 |
Dottino J, He W, Sun CC, Zhao H, Lu KH, Meyer L. National patient experience data and correlation with in-hospital adverse gynecologic cancer surgical outcomes. Journal of Clinical Oncology. 36: 21-21. DOI: 10.1200/Jco.2018.36.30_Suppl.21 |
0.367 |
|
| 2018 |
Suidan RS, Sun CC, Lu KH, Giordano SH, Meyer L. Patient, clinician, and non-patient perceptions of surgical complications in ovarian cancer. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E22159 |
0.424 |
|
| 2017 |
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH. A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment. Gynecologic Oncology. PMID 28610746 DOI: 10.1016/J.Ygyno.2017.05.037 |
0.404 |
|
| 2017 |
Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28574929 DOI: 10.1097/Igc.0000000000000998 |
0.367 |
|
| 2017 |
Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecologic Oncology. PMID 28528918 DOI: 10.1016/J.Ygyno.2017.05.016 |
0.337 |
|
| 2017 |
Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28399031 DOI: 10.1097/Igc.0000000000000953 |
0.323 |
|
| 2017 |
Gershenson DM, Bodurka DC, Coleman RL, Lu KH, Malpica A, Sun CC. Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016710632. PMID 28221866 DOI: 10.1200/Jco.2016.71.0632 |
0.419 |
|
| 2017 |
Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 28175997 DOI: 10.1007/S00520-017-3605-Z |
0.342 |
|
| 2017 |
Dalton HJ, Fleming ND, Sun CC, Bhosale P, Schmeler KM, Gershenson DM. Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience. Gynecologic Oncology. PMID 28139261 DOI: 10.1016/J.Ygyno.2017.01.027 |
0.408 |
|
| 2017 |
Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp A, Fleming ND, Lu KH, Giordano SH, Meyer L. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial carcinoma. Journal of Clinical Oncology. 35: 9-9. DOI: 10.1200/Jco.2017.35.8_Suppl.9 |
0.37 |
|
| 2017 |
Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer L. A cost-utility analysis of sentinel lymph node mapping, selective lymphadenectomy, and routing lymphadenectomy in the management of low-risk endometrial cancer. Journal of Clinical Oncology. 35: 10-10. DOI: 10.1200/Jco.2017.35.8_Suppl.10 |
0.353 |
|
| 2017 |
Meyer L, Shi Q, Iniesta M, Harris M, Sun CC, Lasala J, Wang S, Nick AM, Lu KH, Ramirez PT. Comparison of patient reported symptom burden in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Journal of Clinical Oncology. 35: 5557-5557. DOI: 10.1200/Jco.2017.35.15_Suppl.5557 |
0.397 |
|
| 2017 |
Meyer L, Nick A, Shi Q, Iniesta M, Lasala J, Harris M, Sun C, Lu K, Ramirez P. Comparison of longitudinal patient reported outcomes on an enhanced recovery pathway in patients with ovarian cancer undergoing primary vs interval cytoreductive surgery Gynecologic Oncology. 145: 207-208. DOI: 10.1016/J.YGYNO.2017.03.477 |
0.318 |
|
| 2016 |
Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Review of Quality of Life in Cancer Care. 1: 231-238. PMID 30906877 DOI: 10.1080/23809000.2016.1185369 |
0.32 |
|
| 2016 |
Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AA. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27601552 DOI: 10.1200/Jco.2016.68.1239 |
0.43 |
|
| 2016 |
Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Annals of Surgical Oncology. PMID 27573526 DOI: 10.1245/S10434-016-5517-4 |
0.552 |
|
| 2016 |
Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, et al. Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. Jama Oncology. PMID 27442965 DOI: 10.1001/Jamaoncol.2016.1842 |
0.348 |
|
| 2016 |
Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC. Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecologic Oncology. PMID 27439968 DOI: 10.1016/J.Ygyno.2016.07.010 |
0.353 |
|
| 2016 |
Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT. Endometrial Cancer Associated Symptoms: A Case-Control Study. Journal of Women's Health (2002). PMID 27254529 DOI: 10.1089/Jwh.2015.5657 |
0.374 |
|
| 2016 |
Ganeshan D, Bhosale P, Wei W, Ramalingam P, Mudasiru-Dawodu E, Gershenson D, Sun C, Iyer R. Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer. Abdominal Radiology (New York). PMID 26969496 DOI: 10.1007/S00261-016-0701-3 |
0.327 |
|
| 2016 |
Suidan RS, He W, Sun CC, Soliman PT, Ramirez PT, Zhao H, Fleming ND, Westin SN, Lu KH, Giordano SH, Meyer L. Impact of body mass index on surgical costs and morbidity for women with endometrial carcinoma/hyperplasia. Journal of Clinical Oncology. 34: 5583-5583. DOI: 10.1200/Jco.2016.34.15_Suppl.5583 |
0.339 |
|
| 2016 |
Bednar E, Oakley HD, Sun CC, Westin SN, Lu KH. Universal germline BRCA testing of ovarian cancer patients and implications for treatment. Journal of Clinical Oncology. 34: 5539-5539. DOI: 10.1200/Jco.2016.34.15_Suppl.5539 |
0.425 |
|
| 2016 |
Nebgen DR, Holman LL, Hurteau J, Keeler E, Chisholm GB, Sun CC, Lu KH. Prophylactic salpingectomy with delayed oophorectomy (PSDO): Feasibility study in women with BRCA mutations. Journal of Clinical Oncology. 34: 1506-1506. DOI: 10.1200/Jco.2016.34.15_Suppl.1506 |
0.39 |
|
| 2016 |
Armbruster SD, Sun CC, Soliman PT, Westin SN, Bodurka DC, Ramondetta LM, Bradford AM, Basen-Engquist K. Prospective assessment of patient perception and quality of life in gynecologic patients after pelvic exenteration. Journal of Clinical Oncology. 34: 10082-10082. DOI: 10.1200/Jco.2016.34.15_Suppl.10082 |
0.417 |
|
| 2016 |
Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun CC, O'Malley DM, et al. Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer Obstetrical & Gynecological Survey. 71: 660-661. DOI: 10.1097/Ogx.0000000000000377 |
0.325 |
|
| 2016 |
Taylor J, Marten C, Sun C, Bodurka D, Potts K, Nick A, Meyer L, Levenback C, Lairson D, Schmeler K. The cost-effectiveness of the DISINFECT Initiative (Decreasing the Incidence of Surgical INFECTions) in gynecologic oncology Gynecologic Oncology. 141: 87. DOI: 10.1016/J.YGYNO.2016.04.241 |
0.484 |
|
| 2015 |
Taylor JS, Brown AJ, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. Dying well: How equal is end of life care among gynecologic oncology patients? Gynecologic Oncology. PMID 26706661 DOI: 10.1016/J.Ygyno.2015.12.012 |
0.322 |
|
| 2015 |
Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CC. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecologic Oncology. PMID 26498912 DOI: 10.1016/J.Ygyno.2015.10.017 |
0.379 |
|
| 2015 |
Gershenson DM, Sun CC, Wong KK. Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum. British Journal of Cancer. 113: 1254-8. PMID 26484411 DOI: 10.1038/Bjc.2015.364 |
0.322 |
|
| 2015 |
Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecologic Oncology. PMID 26432043 DOI: 10.1200/Jco.2015.33.29_Suppl.104 |
0.397 |
|
| 2015 |
Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC. Survivors of gynecologic malignancies: impact of treatment on health and well-being. Journal of Cancer Survivorship : Research and Practice. PMID 26245979 DOI: 10.1097/Ogx.0000000000000253 |
0.327 |
|
| 2015 |
Gershenson DM, Bodurka DC, Lu KH, Nathan LC, Milojevic L, Wong KK, Malpica A, Sun CC. Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26195696 DOI: 10.1200/Jco.2015.61.0873 |
0.393 |
|
| 2015 |
Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients. Gynecologic Oncology. PMID 25988961 DOI: 10.1016/J.Ygyno.2015.05.005 |
0.413 |
|
| 2015 |
Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM. Targeting those with decreased meaning and peace: a supportive care opportunity. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 2025-32. PMID 25519758 DOI: 10.1007/S00520-014-2568-6 |
0.335 |
|
| 2015 |
Prescott LS, Aloia TA, Brown AJ, Taylor JS, Munsell MF, Sun CC, Schmeler KM, Levenback CF, Bodurka DC. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecologic Oncology. 136: 65-70. PMID 25451693 DOI: 10.1016/J.Ygyno.2014.11.009 |
0.312 |
|
| 2015 |
Crane EK, Sun CC, Ramirez PT, Schmeler KM, Malpica A, Gershenson DM. The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer. Gynecologic Oncology. 136: 25-9. PMID 25448453 DOI: 10.1016/J.Ygyno.2014.11.005 |
0.463 |
|
| 2015 |
Brown J, Taylor K, Ramirez PT, Sun C, Holman LL, Cone SM, Irwin J, Frumovitz M. Laparoscopic supracervical hysterectomy with morcellation: should it stay or should it go? Journal of Minimally Invasive Gynecology. 22: 185-92. PMID 25242233 DOI: 10.1016/J.Jmig.2014.09.005 |
0.452 |
|
| 2015 |
Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT. Symptoms of endometrial cancer. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E16501 |
0.361 |
|
| 2015 |
Meyer L, Cronin A, Sun CC, Bookman MA, Burger RA, Cristea MC, Griggs JJ, Levenback CF, Mantia-Smaldone G, Matulonis U, Niland JC, O'Malley DM, Wright AA. Use of neoadjuvant chemotherapy in advanced ovarian cancer. Journal of Clinical Oncology. 33: 5563-5563. DOI: 10.1200/Jco.2015.33.15_Suppl.5563 |
0.434 |
|
| 2014 |
Brown AJ, Sun CC, Levenback CF, Ramondetta LM, Bodurka DC. Transfusion utilization at the end of life. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 303. PMID 28141432 DOI: 10.1200/Jco.2014.32.30_Suppl.303 |
0.318 |
|
| 2014 |
Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC. Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients. Gynecologic Oncology. 135: 244-8. PMID 25192878 DOI: 10.1016/j.ygyno.2014.03.539 |
0.379 |
|
| 2014 |
Sun CC, Brown AJ, Jhingran A, Frumovitz M, Ramondetta LM, Bodurka DC. Patient preferences for side effects associated with cervical cancer treatment. International Journal of Gynecological Cancer. 24: 1077-1084. PMID 24905618 DOI: 10.1097/Igc.0000000000000149 |
0.436 |
|
| 2014 |
Solheim O, Gershenson DM, Tropé CG, Rokkones E, Sun CC, Weedon-Fekjaer H, Fosså SD. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010). European Journal of Cancer (Oxford, England : 1990). 50: 1942-50. PMID 24857045 DOI: 10.1016/J.Ejca.2014.03.288 |
0.393 |
|
| 2014 |
Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR. Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer Cancer Prevention Research. 7: 686-697. PMID 24771847 DOI: 10.1158/1940-6207.Capr-13-0359 |
0.411 |
|
| 2014 |
Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH. Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecologic Oncology. 133: 283-6. PMID 24582866 DOI: 10.1016/J.Ygyno.2014.02.030 |
0.452 |
|
| 2014 |
Schlumbrecht MP, Sun CC, Huang MS, Zandstra F, Bodurka DC. Lifestyle modification in cervical cancer survivors: an ongoing need. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 24: 570-5. PMID 24469324 DOI: 10.1016/J.Ygyno.2010.12.260 |
0.404 |
|
| 2014 |
Holman LL, Lu KH, Bast RC, Hernandez MA, Bodurka DC, Skates S, Sun CC. Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. American Journal of Obstetrics and Gynecology. 210: 257.e1-6. PMID 24246524 DOI: 10.1016/J.Ajog.2013.11.022 |
0.418 |
|
| 2014 |
Burton-Chase AM, Hovick SR, Sun CC, Boyd-Rogers S, Lynch PM, Lu KH, Peterson SK. Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome. Clinical Genetics. 86: 185-9. PMID 23906188 DOI: 10.1111/Cge.12246 |
0.372 |
|
| 2014 |
Solheim O, Gershenson DM, Trope C, Rokkones E, Sun CC, Fekjaer HW, Fossa S. Prognostic factors in malignant ovarian germ cell tumors: The SEER experience 1978-2010. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E15534 |
0.362 |
|
| 2014 |
Meyer L, He W, Zhao H, Sun CC, Buchholz TA, Lu KH, Giordano SH. Patterns of care and overall survival in the Medicare ovarian cancer population. Journal of Clinical Oncology. 32: 5587-5587. DOI: 10.1200/Jco.2014.32.15_Suppl.5587 |
0.418 |
|
| 2014 |
Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun CC, Lu KH, Broaddus R. Evaluation of clinical criteria for the identification of lynch syndrome among unselected endometrial cancer patients Obstetrical & Gynecological Survey. 69: 541-542. DOI: 10.1097/Ogx.0000000000000098 |
0.388 |
|
| 2014 |
Prescott L, Sun C, Schmeler K, Aloia T, Munsell M, Bodurka D. Abstract number 16: Transfusion utilization during ovarian cancer surgery and effect on perioperative outcomes: Analysis of National Surgical Quality Improvement Program Database Gynecologic Oncology. 134: 435-436. DOI: 10.1016/J.Ygyno.2014.04.034 |
0.363 |
|
| 2014 |
Brown A, Sun C, Prescott L, Ramondetta L, Bodurka D. An afterthought: End-of-life care documentation among ovarian cancer patients Gynecologic Oncology. 133: 202-203. DOI: 10.1016/J.YGYNO.2014.03.540 |
0.302 |
|
| 2013 |
Likhacheva A, Jhingran A, Bodurka DC, Sun CC, Sam M, Eifel PJ. Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil. International Journal of Gynecological Cancer. 23: 1520-1527. PMID 24257567 DOI: 10.1097/Igc.0B013E3182A0C0E5 |
0.345 |
|
| 2013 |
Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, et al. A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value. Cancer. 119: 3454-61. PMID 23983047 DOI: 10.1097/01.Ogx.0000442828.54138.67 |
0.423 |
|
| 2013 |
Huang M, Djordjevic B, Yates MS, Urbauer D, Sun C, Burzawa J, Daniels M, Westin SN, Broaddus R, Lu K. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer. 119: 3027-33. PMID 23760948 DOI: 10.1002/Cncr.28152 |
0.373 |
|
| 2013 |
Romero I, Sun CC, Wong KK, Bast RC, Gershenson DM. Low-grade serous carcinoma: new concepts and emerging therapies. Gynecologic Oncology. 130: 660-6. PMID 23707670 DOI: 10.1016/J.Ygyno.2013.05.021 |
0.414 |
|
| 2013 |
Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecologic Oncology. 130: 323-8. PMID 23685012 DOI: 10.1016/J.Ygyno.2013.05.009 |
0.412 |
|
| 2013 |
Williams LA, Agarwal S, Bodurka DC, Saleeba AK, Sun CC, Cleeland CS. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. Journal of Pain and Symptom Management. 46: 837-45. PMID 23615044 DOI: 10.1016/J.Jpainsymman.2013.02.007 |
0.352 |
|
| 2013 |
Huang M, Sun CC, Westin SN, Bodurka DC. Hormone replacement therapy (HRT) prescribing patterns among gynecologic oncologists. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E20637 |
0.33 |
|
| 2013 |
Soliman PT, Sun CC, Westin SN, Ramondetta LM, Bodurka DC, Bradford A. Longitudinal quality of life (QOL) and sexual functioning in women undergoing pelvic exenteration for gynecologic malignancies. Journal of Clinical Oncology. 31: 5608-5608. DOI: 10.1200/Jco.2013.31.15_Suppl.5608 |
0.343 |
|
| 2013 |
Brown AJ, Huang M, Sun CC, Zaid TM, Balakrishnan N, Mhadgut H, Lu KH, Westin SN, Bodurka DC. Benefits of neoadjuvant chemotherapy in ovarian, primary peritoneal, or fallopian tube carcinoma. Journal of Clinical Oncology. 31: 5580-5580. DOI: 10.1200/Jco.2013.31.15_Suppl.5580 |
0.355 |
|
| 2013 |
Westin S, Sun C, Pal N, Janku F, Tsimberidou A, Falchook G, Hong D, Lu K, Coleman R, Kurzrock R. KRAS mutation in endometrial and ovarian cancers: Preliminary data on association with phenotype and clinical outcome in primary disease Gynecologic Oncology. 130: e162. DOI: 10.1016/J.Ygyno.2013.04.453 |
0.364 |
|
| 2013 |
Holman L, Lu K, Hernandez M, Bast R, Neal S, Skates S, Gershenson D, Sun C. Changes in perceptions of screening over time among average-risk women undergoing ovarian cancer screening using the risk of ovarian cancer algorithm Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.133 |
0.393 |
|
| 2012 |
Noguera IR, Sun CC, Broaddus RR, Branham D, Levenback CF, Ramirez PT, Sood AK, Coleman RL, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube. Gynecologic Oncology. 125: 640-5. PMID 22387451 DOI: 10.1016/J.Ygyno.2012.02.034 |
0.343 |
|
| 2012 |
Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, et al. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer. 118: 3087-94. PMID 22072418 DOI: 10.1002/Cncr.26618 |
0.4 |
|
| 2012 |
Pentz RD, Liu Y, Wall L, Daugherty C, Green MJ, Hlubocky FJ, Peterson SK, Sun CC, Dixon M, Harvey RD, Owonikoko TK, Khuri FR. Physicians’ ability to correctly identify values important to cancer patients enrolled in phase I clinical trials. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E13026 |
0.355 |
|
| 2012 |
Milbourne A, Sun CC, Fanale MA, Theriault RL, Rimes SA, Litton JK, Ramirez MM. Pregnancy outcomes in women with cancer. Journal of Clinical Oncology. 30: 6116-6116. DOI: 10.1200/Jco.2012.30.15_Suppl.6116 |
0.425 |
|
| 2012 |
Holman LL, Daniels MS, Brandt AC, Arun B, Keeler E, Gershenson DM, Sun CC, Lu KH. Risk-reducing salpingo-oophorectomy and prophylactic mastectomy among BRCA mutation “previvors.” Journal of Clinical Oncology. 30: 1518-1518. DOI: 10.1200/Jco.2012.30.15_Suppl.1518 |
0.432 |
|
| 2012 |
Schlumbrecht M, Sun CC, Huang M, Milbourne A, Bodurka D. Survivorship Care: Who Do Gynecologic Cancer Patients Prefer? Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2012.01.045 |
0.399 |
|
| 2012 |
Holman L, Lu K, Hernandez M, Bast R, Bodurka D, Skates S, Gershenson D, Sun C. Perception of risk, cancer worry, anxiety, and acceptability of screening among low-risk women undergoing ovarian cancer screening with the risk of ovarian cancer algorithm Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.281 |
0.401 |
|
| 2012 |
Sun C, Jhingran A, Gallegos J, Bodurka D, Frumovitz M, Ramondetta L. Longitudinal quality of life in medically underserved women with locally advanced cervical cancer Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.118 |
0.367 |
|
| 2012 |
Westin S, Sun C, Broaddus R, Pal N, Nath V, Urbauer D, Schmeler K, Lu K, Bodurka D, Johnston T. Prospective phase II trial of the Levonorgestrel Intrauterine System (Mirena) to treat complex atypical hyperplasia and grade 1 endometrioid endometrial cancer Gynecologic Oncology. 125. DOI: 10.1016/J.Ygyno.2011.12.016 |
0.336 |
|
| 2012 |
Likhacheva A, Jhingran A, Bodurka DC, Sun CC, Sam M, Eifel PJ. Patient-reported Acute Symptoms During Chemoradiation for Cervical Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1733 |
0.381 |
|
| 2011 |
Pentz RD, Farmer ZL, Green MJ, Daugherty C, Hlubocky FJ, Peterson SK, Sun CC, Lewis CM, Owonikoko TK, Khuri FR, Harvey RD. Assessing patients' values when standard-of-care options are exhausted. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 9108. PMID 28021822 DOI: 10.1200/Jco.2011.29.15_Suppl.9108 |
0.348 |
|
| 2011 |
Ready K, Arun BK, Schmeler KM, Uyei A, Litton JK, Lu KH, Sun CC, Peterson SK. Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center. Familial Cancer. 10: 673-9. PMID 21681553 DOI: 10.1007/S10689-011-9460-Z |
0.335 |
|
| 2011 |
Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer. 117: 2659-67. PMID 21656744 DOI: 10.1002/Cncr.25820 |
0.426 |
|
| 2011 |
Kwon JS, Scott JL, Gilks CB, Daniels MS, Sun CC, Lu KH. Testing women with endometrial cancer to detect Lynch syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2247-52. PMID 21537049 DOI: 10.1200/Jco.2010.32.9979 |
0.435 |
|
| 2011 |
Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. Journal of Oncology Practice / American Society of Clinical Oncology. 7: 43-7. PMID 21532810 DOI: 10.1200/Jop.2010.000038 |
0.431 |
|
| 2011 |
Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 517-22. PMID 21436700 DOI: 10.1097/Igc.0B013E31820Da9E2 |
0.372 |
|
| 2011 |
Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM. Low-grade serous primary peritoneal carcinoma. Gynecologic Oncology. 121: 482-6. PMID 21397305 DOI: 10.1016/J.Ygyno.2011.02.017 |
0.447 |
|
| 2011 |
Schlumbrecht MP, Sun CC, Wong KN, Broaddus RR, Gershenson DM, Bodurka DC. Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma. Cancer. 117: 3741-9. PMID 21319148 DOI: 10.1002/Cncr.25929 |
0.396 |
|
| 2011 |
Agarwal S, Schmeler KM, Ramirez PT, Sun CC, Nick A, Dos Reis R, Brown J, Frumovitz M. Outcomes of patients undergoing radical hysterectomy for cervical cancer of high-risk histological subtypes. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 21: 123-7. PMID 21178574 DOI: 10.1097/Igc.0B013E3181Ffccc1 |
0.463 |
|
| 2011 |
Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH. Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer? Gynecologic Oncology. 120: 229-32. PMID 21126756 DOI: 10.1016/J.Ygyno.2010.10.033 |
0.433 |
|
| 2011 |
Schlumbrecht MP, Gallagher CM, Sun CC, Ramondetta LM, Bodurka DC. Ethics consultation on a gynecologic oncology service: an opportunity for physician education. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 26: 183-7. PMID 20835927 DOI: 10.1007/S13187-010-0154-2 |
0.33 |
|
| 2011 |
Burton AM, Sun CC, Daniels MS, Boyd-Rogers S, Lynch PM, Lu KH, Peterson SK. Abstract B29: Screening and communication with physicians for women with Lynch syndrome: Findings from a qualitative study Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B29 |
0.373 |
|
| 2011 |
Huang M, Westin S, Sun C, Meyer L, Tung C, Urbauer D, Bodurka D. Menopausal symptoms and use of hormone replacement therapy: The gynecologic cancer survivors' perspective Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.196 |
0.34 |
|
| 2011 |
Bodurka D, Sun C, Jhingran A, Urbauer D, Levenback C, Eifel P, Ramondetta L, Ramirez P, Frumovitz M, Schover L. A longitudinal evaluation of sexual functioning and quality of life in cervical cancer survivors Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.194 |
0.322 |
|
| 2011 |
Iglesias D, Sun C, Langstraat C, Bakkum-Gamez J, El-Nashar S, Keeler E, Gershenson D, Lu K. Management and clinical outcomes of women with BRCA1/2 mutations found to have occult cancers at the time of risk-reducing salpingo-oophorectomy Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.144 |
0.371 |
|
| 2010 |
Avritscher EB, Shih YC, Sun CC, Gralla RJ, Grunberg SM, Xu Y, Elting LS. Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. The Journal of Supportive Oncology. 8: 242-51. PMID 21265391 DOI: 10.1016/J.Suponc.2010.09.027 |
0.307 |
|
| 2010 |
Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstetrics and Gynecology. 116: 1358-65. PMID 21099603 DOI: 10.1097/Aog.0B013E3181Fb8045 |
0.38 |
|
| 2010 |
Kwon JS, Gutierrez-Barrera AM, Young D, Sun CC, Daniels MS, Lu KH, Arun B. Expanding the criteria for BRCA mutation testing in breast cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4214-20. PMID 20733129 DOI: 10.1200/Jco.2010.28.0719 |
0.395 |
|
| 2010 |
Schmeler KM, Tao X, Frumovitz M, Deavers MT, Sun CC, Sood AK, Brown J, Gershenson DM, Ramirez PT. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstetrics and Gynecology. 116: 269-73. PMID 20664385 DOI: 10.1097/Aog.0B013E3181E7961D |
0.312 |
|
| 2010 |
Brandt AC, Tschirgi ML, Ready KJ, Sun C, Darilek S, Hecht J, Arun BK, Lu KH. Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes. Familial Cancer. 9: 479-87. PMID 20431955 DOI: 10.1007/S10689-010-9343-8 |
0.422 |
|
| 2010 |
Ready KJ, Daniels MS, Sun CC, Peterson SK, Northrup H, Lu KH. Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 25: 401-4. PMID 20186516 DOI: 10.1007/S13187-010-0063-4 |
0.366 |
|
| 2010 |
Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Annals of Surgical Oncology. 17: 1794-801. PMID 20162463 DOI: 10.1245/S10434-010-0943-1 |
0.357 |
|
| 2010 |
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 116: 625-30. PMID 20052724 DOI: 10.1002/Cncr.24811 |
0.377 |
|
| 2010 |
Kwon JS, Daniels MS, Sun CC, Lu KH. Preventing future cancers by testing women with ovarian cancer for BRCA mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 675-82. PMID 19841329 DOI: 10.1200/Jco.2008.21.4684 |
0.419 |
|
| 2009 |
Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC. Survival after intestinal perforation: can it be predicted? Gynecologic Oncology. 115: 349-53. PMID 19765809 DOI: 10.1016/J.Ygyno.2009.08.013 |
0.37 |
|
| 2009 |
Frumovitz M, Sun CC, Schmeler KM, Deavers MT, Reis RD, Levenback CF, Ramirez PT. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer Obstetrics and Gynecology. 114: 93-99. PMID 19546764 DOI: 10.1097/Aog.0B013E3181Ab474D |
0.436 |
|
| 2009 |
Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecologic Oncology. 114: 48-52. PMID 19361839 DOI: 10.1016/J.Ygyno.2009.03.001 |
0.391 |
|
| 2009 |
Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer. 115: 1598-604. PMID 19280625 DOI: 10.1002/Cncr.24199 |
0.392 |
|
| 2009 |
Ramondetta LM, Johnson AJ, Sun CC, Atkinson N, Smith JA, Jung MS, Broaddus R, Iyer RB, Burke T. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 115: 1867-74. PMID 19241422 DOI: 10.1002/Cncr.24197 |
0.445 |
|
| 2009 |
Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Annals of Surgical Oncology. 16: 836-47. PMID 19194760 DOI: 10.1245/S10434-008-0295-2 |
0.31 |
|
| 2008 |
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz MM, Bodurka DC, Sood AK. Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5530. PMID 27950486 DOI: 10.1200/Jco.2008.26.15_Suppl.5530 |
0.314 |
|
| 2008 |
Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstetrics and Gynecology. 112: 899-905. PMID 18827134 DOI: 10.1097/Aog.0B013E3181863280 |
0.34 |
|
| 2008 |
Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3496-502. PMID 18640930 DOI: 10.1200/Jco.2007.15.8634 |
0.376 |
|
| 2008 |
Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3487-95. PMID 18640929 DOI: 10.1200/Jco.2007.15.8642 |
0.374 |
|
| 2008 |
Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH. Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer. 113: 326-35. PMID 18506736 DOI: 10.1002/Cncr.23554 |
0.382 |
|
| 2008 |
Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. Journal of the American College of Surgeons. 206: 833-46; discussion 8. PMID 18471707 DOI: 10.1016/J.Jamcollsurg.2007.12.020 |
0.384 |
|
| 2008 |
Jones KL, Saucier JM, Sun CC, Bevers MW, Ramondetta LM, Brown J, Smith JA. Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 14: 31-6. PMID 18337438 DOI: 10.1177/1078155207082947 |
0.325 |
|
| 2008 |
Westin SN, Bustillos D, Gano JB, Fields MM, Coker AL, Sun CC, Ramondetta LM. Social factors affecting treatment of cervical cancer: ethical issues and policy implications. Obstetrics and Gynecology. 111: 747-51. PMID 18310380 DOI: 10.1097/Aog.0B013E318165F1A9 |
0.332 |
|
| 2008 |
Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Malpica A, Coleman RL, Ramirez PT, Gershenson DM. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecologic Oncology. 108: 510-4. PMID 18155273 DOI: 10.1016/J.Ygyno.2007.11.013 |
0.39 |
|
| 2008 |
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures following radiation therapy for cervical cancer: Implications for survivors Gynecologic Oncology. 111: 382. DOI: 10.1016/J.Ygyno.2008.07.083 |
0.311 |
|
| 2007 |
Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RR. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5158-64. PMID 17925543 DOI: 10.1200/Jco.2007.10.8597 |
0.38 |
|
| 2007 |
Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 18: 660-9. PMID 17892451 DOI: 10.1111/J.1525-1438.2007.01081.X |
0.456 |
|
| 2007 |
dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecologic Oncology. 107: 458-63. PMID 17854872 DOI: 10.1016/J.Ygyno.2007.07.080 |
0.423 |
|
| 2007 |
Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, Slomovitz BM, Ramirez PT. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstetrics and Gynecology. 110: 96-102. PMID 17601902 DOI: 10.1097/01.Aog.0000268798.75353.04 |
0.325 |
|
| 2007 |
Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Annals of Surgery. 246: 52-60. PMID 17592291 DOI: 10.1097/01.Sla.0000259391.84304.2B |
0.312 |
|
| 2007 |
Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecologic Oncology. 105: 625-9. PMID 17320156 DOI: 10.1016/J.Ygyno.2007.01.030 |
0.338 |
|
| 2007 |
Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DM. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Gynecologic Oncology. 105: 404-8. PMID 17292461 DOI: 10.1016/J.Ygyno.2006.12.024 |
0.354 |
|
| 2007 |
Sun CC, Ramirez PT, Bodurka DC. Quality of life for patients with epithelial ovarian cancer. Nature Clinical Practice. Oncology. 4: 18-29. PMID 17183353 DOI: 10.1038/Ncponc0693 |
0.443 |
|
| 2007 |
Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Coleman RL, Ramirez PT, Gershenson DM. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary Journal of Clinical Oncology. 25: 5571-5571. DOI: 10.1200/Jco.2007.25.18_Suppl.5571 |
0.348 |
|
| 2007 |
Lacour RA, Westin SN, Daniels MS, Milam MR, Sun CC, Urbauer DL, Ramirez PT, Bodurka DC, Gershenson DM, Lu KH. Survival in advanced-stage ovarian cancer patients with non-Ashkenazi Jewish BRCA mutations Journal of Clinical Oncology. 25: 5514-5514. DOI: 10.1200/Jco.2007.25.18_Suppl.5514 |
0.409 |
|
| 2007 |
Sun CC, Westin SN, Lu KH, Schmeler KM, White KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Impact of BRCA 1/2 testing: Body image, sexual functioning, and quality of life (QOL) Journal of Clinical Oncology. 25: 1525-1525. DOI: 10.1200/Jco.2007.25.18_Suppl.1525 |
0.325 |
|
| 2007 |
Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, White KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Management strategies for women at high risk for breast and ovarian cancer: Are women satisfied? Journal of Clinical Oncology. 25: 1524-1524. DOI: 10.1200/Jco.2007.25.18_Suppl.1524 |
0.445 |
|
| 2006 |
Bodurka DC, Sun CC. Sexual function after gynecologic cancer. Obstetrics and Gynecology Clinics of North America. 33: 621-30, ix. PMID 17116505 DOI: 10.1016/J.Ogc.2006.09.006 |
0.369 |
|
| 2006 |
Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstetrics and Gynecology. 108: 515-20. PMID 16946209 DOI: 10.1097/01.Aog.0000228959.30577.13 |
0.398 |
|
| 2006 |
Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstetrics and Gynecology. 108: 361-8. PMID 16880307 DOI: 10.1097/01.Aog.0000227787.24587.D1 |
0.381 |
|
| 2006 |
Ramondetta LM, Sun CC, Hollier L, Jarrett LT, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy Gynecologic Oncology. 103: 547-553. PMID 16730784 DOI: 10.1016/J.Ygyno.2006.03.054 |
0.378 |
|
| 2006 |
Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DC. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 106: 2452-8. PMID 16639738 DOI: 10.1002/Cncr.21907 |
0.323 |
|
| 2006 |
Wolf JK, Bodurka DC, Verschraegen C, Sun CC, Branham D, Jenkins AD, Atkinson N, Gershenson DM. A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer. Gynecologic Oncology. 102: 468-74. PMID 16516276 DOI: 10.1016/J.Ygyno.2005.12.040 |
0.377 |
|
| 2006 |
Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. The New England Journal of Medicine. 354: 261-9. PMID 16421367 DOI: 10.1097/01.Ogx.0000216536.75662.99 |
0.449 |
|
| 2006 |
Sun CC, Peterson SK, White KG, Watts BG, Daniels MS, Boyd-Rogers SG, Schmeler KM, Bodurka DC, Lu KH. Preferences for cancer prevention strategies (CPS) in women with hereditary nonpolyposis colectal cancer (HNPCC) Journal of Clinical Oncology. 24: 1018-1018. DOI: 10.1200/Jco.2006.24.18_Suppl.1018 |
0.409 |
|
| 2005 |
Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7428-36. PMID 16234510 DOI: 10.1200/Jco.2004.00.3996 |
0.42 |
|
| 2005 |
Sun CC, Frumovitz M, Bodurka DC. Quality of life and gynecologic malignancies. Current Oncology Reports. 7: 459-65. PMID 16221383 DOI: 10.1007/S11912-005-0011-3 |
0.349 |
|
| 2005 |
Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Endometrial cancer in young, normal-weight women. Gynecologic Oncology. 99: 388-92. PMID 16051336 DOI: 10.1016/J.Ygyno.2005.06.029 |
0.343 |
|
| 2005 |
Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecologic Oncology. 97: 840-4. PMID 15882895 DOI: 10.1016/J.Ygyno.2005.02.029 |
0.356 |
|
| 2005 |
Bodurka DC, Sun CC, Frumovitz MM. Quality of life in cervix cancer survivors--what matters the most in the long-term? Gynecologic Oncology. 97: 307-9. PMID 15863122 DOI: 10.1016/J.Ygyno.2005.03.014 |
0.312 |
|
| 2005 |
Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstetrics and Gynecology. 105: 575-80. PMID 15738027 DOI: 10.1097/01.Aog.0000154151.14516.F7 |
0.445 |
|
| 2005 |
Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, et al. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstetrics and Gynecology. 105: 569-74. PMID 15738026 DOI: 10.1097/01.Aog.0000154885.44002.Ae |
0.443 |
|
| 2005 |
Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 13: 219-27. PMID 15538640 DOI: 10.1007/S00520-004-0710-6 |
0.476 |
|
| 2004 |
Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecologic Oncology. 95: 133-8. PMID 15385122 DOI: 10.1016/J.Ygyno.2004.06.045 |
0.398 |
|
| 2004 |
Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HM. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 101: 1514-23. PMID 15378473 DOI: 10.1002/Cncr.20529 |
0.335 |
|
| 2004 |
Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. Journal of the American College of Surgeons. 199: 388-93. PMID 15325608 DOI: 10.1016/J.Jamcollsurg.2004.05.258 |
0.361 |
|
| 2004 |
Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecologic Oncology. 94: 456-62. PMID 15297188 DOI: 10.1016/J.Ygyno.2004.05.006 |
0.506 |
|
| 2004 |
Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstetrics and Gynecology. 104: 255-60. PMID 15291996 DOI: 10.1097/01.Aog.0000131620.67911.03 |
0.43 |
|
| 2004 |
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3126-32. PMID 15284264 DOI: 10.1200/Jco.2004.11.154 |
0.359 |
|
| 2004 |
Smith JA, Kindo CC, Kurian S, Whitaker LM, Burke C, Wachel B, Sun CC, Weaver CL, Danielson MG, Fitzgerald MA, Munsell M, Zandstra FA, Bodurka DC. Evaluation of patient chemotherapy education in a gynecology oncology center. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 12: 577-83. PMID 15168104 DOI: 10.1007/S00520-003-0546-5 |
0.304 |
|
| 2004 |
Tseng JF, Kronowitz SJ, Hunt KK, Sun CC, Babiera GV, Singletary E, Meric-Bernstam F, Ross MJ, Feig BW, Kuerer HM. The rate of immediate reconstruction following mastectomy for breast cancer varies by patient race Annals of Surgical Oncology. 11. DOI: 10.1007/Bf02524097 |
0.346 |
|
| 2003 |
Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Expression of c‐ABL, c‐KIT, and platelet‐derived growth factor receptor‐β in ovarian serous carcinoma and normal ovarian surface epithelium Cancer. 98: 758-764. PMID 12910520 DOI: 10.1002/Cncr.11561 |
0.3 |
|
| 2002 |
Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM. Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecologic Oncology. 87: 118-28. PMID 12468352 DOI: 10.1006/Gyno.2002.6807 |
0.397 |
|
| 2000 |
Bodurka-Bevers D, Sun CC, Gershenson DM. Pharmacoeconomic considerations in treating ovarian cancer. Pharmacoeconomics. 17: 133-50. PMID 10947337 DOI: 10.2165/00019053-200017020-00003 |
0.392 |
|
| 2000 |
Robinson JB, Sun CC, Bodurka-Bevers D, Im DD, Rosenshein NB. Cavitational ultrasonic surgical aspiration for the treatment of vaginal intraepithelial neoplasia. Gynecologic Oncology. 78: 235-241. PMID 10926809 DOI: 10.1006/Gyno.2000.5881 |
0.36 |
|
| Show low-probability matches. |